Received Dec 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z008197 | — |
No side effects or symptoms reported; HCP called to report TE where patient received product after it was improperly stored.; Information has been received from a certified medical assistant (C.M.A) and referred to a 12-month-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 20-Nov-2025, the patient vaccinated with improperly stored Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) injection (lot #Z008197, expiration date: 30-Apr-2027, dose 0.5 mL, strength, frequency and route were unknown) for prophylaxis (Product storage error). The vaccine was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT) (lot# and expiration date were unknown). No side effects or symptoms reported. The stored temperature was 10.5 degree Celsius. The time frame was 1 hour. There was no previous temperature excursion.
sterile diluent